Brief: Carlyle Group Inc Reports 6.7% Passive Stake In Phathom Pharmaceuticals Inc As Of March 1 - SEC Filing
March 9 (Reuters) - Carlyle Group Inc CG.O :
* CARLYLE GROUP INC REPORTS 6.7% PASSIVE STAKE IN PHATHOM
PHARMACEUTICALS INC AS OF MARCH 1 - SEC FILING
Further company coverage: CG.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates